Ruben E. Olmedo

  • ASSISTANT PROFESSOR Emergency Medicine
Print ProfilePrint Profile

Certifications

  • American Board of Emergency Medicine

Clinical Focus

  • Toxicology

Education

  • MD, Albert Einstein College of Medicine

  • Residency, Internal Medicine
    Columbia-Presbyterian Medical Ctr.

  • Residency, Emergency Medicine
    Jacobi Hospital Center

  • Fellowship, Medical Toxicology
    Bellevue Hospital Center

Biography

    Dr. Ruben Olmedo is currently Assistant Professor of Emergency Medicine at The Mount Sinai Hospital. He is the Director of the Division of Toxicology and the Director of Customer Service of the Department of Emergency Medicine.

Awards

  • 2005 - 2006
    Teacher of the Year
    Mount Sinai Hospital Emergency Medicine Residency

  • 2003 - 2004
    Teacher of the Year
    Mount Sinai Hospital Emergency Medicine Residency

Research

Innovative treatment approaches to alcohol withdrawal.
Prophylactic treatment to prevent post traumatic stress syndrome.
Critical care in the poisoned patient.

Publications

Olmedo RE. Chapter 83 Phencyclidine. In: Goldfrank LR, Flomenbaum NE, Lewin N, Weisman RS, Howland MA, Hoffman RS, editors. Goldfrank's Toxicologic Emergencies: 8th edition. Stamford, CT, Appleton & Lange;.

Olmedo RE, Hoffman RS. Chapter 75 ; Cocaine. In: Brent J, Phillips S, Buckwalter W, editors. Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient. Mosby Yearbook Publishers;.

Olmedo RE, Hoffman RS, Jagoda A, Reggio S. Withdrawal Syndromes. In: Emergency Medicine Clinics of North America. Philadelphia, PA, W. B. Saunders Company; pp273-288.

Dittmar P, Olmedo RE. Cocaine Associated Emergencies. Emergency Medicine Practice 2008; 1.

Ginsberg BY, Olmedo RE. Cardiovascular Toxins. Emergency Medicine Practice 2008; 1.

Olmedo RE. Chapter 69: Phencyclidine. In: Goldfrank LR, Flomenbaum NE, Lewin N, Weisman RS, Howland MA, Hoffman RS, editors. Goldfrank's Toxicologic Emergencies: 7th edition. Stamford, CT, Appleton & Lange;.

Hamilton RJ, Olmedo RE, Sach S, E. Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets. Acad Emerg Med 2002; 9: 63-68.

Olmedo RE, Nelson LS, Chu J, Hoffman RS. Is surgical decontamination necessary for definite treatment of body packers? . Am J Emerg Med 2001; 19: 593-596.

Lahn M, Gallagher EJ, Li SF, Tauger M, Olmedo RE. Low rates of arrest among intoxicated drivers in motor vehicle collisions, in spite of police presence at the scene and clinically evident inebriation. Acad Emerg Med 2000; 4: 5.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Olmedo did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

One Gustave L. Levy Place
Box 1149
New York, NY 10029

Tel: 212-241-6794
Fax: 212-427-2180